| Kaitlyn E Sizemore, PA-C | |
|
450b Washington Jackson Rd, Eaton, OH 45320-7600 | |
| (937) 456-8360 | |
| (866) 585-5451 |
| Full Name | Kaitlyn E Sizemore |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 450b Washington Jackson Rd, Eaton, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891163580 | NPI | - | NPPES |
| 0144994 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50.004467 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kaitlyn E Sizemore, PA-C 450b Washington Jackson Rd, Eaton, OH 45320-7600 Ph: (937) 456-8360 | Kaitlyn E Sizemore, PA-C 450b Washington Jackson Rd, Eaton, OH 45320-7600 Ph: (937) 456-8360 |
News Archive
A new University of Alabama at Birmingham research paper published in the journal Diabetes Research and Clinical Practice shows for the first time that there is an association of verapamil use and lower fasting glucose levels in humans with diabetes.
Harvard Stem Cell Institute scientists at Boston Children's Hospital have new evidence in mice that it may be possible to repair a chronically diseased liver by forcing mature liver cells to revert back to a stem cell-like state.
Drugs taken by kidney transplant recipients to prevent organ rejection carry similar risks of cancer, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that no single medication is to blame for the higher incidence of cancer seen among patients who have undergone transplantation.
NephRx Corporation today announced issuance of a new U.S. patent for use of its novel growth factor peptide NX002 as a potential treatment for inflammatory bowel disease.
Cerevance, a clinical-stage drug discovery and development company focused on brain diseases, today announced the start of dosing in a Phase I first-in-human clinical trial of CVN424, an oral compound being developed for symptomatic treatment of Parkinson's disease.
› Verified 7 days ago
Mrs. Kasidy Gail Depew, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 450b Washington Jackson Rd, Suite 102, Eaton, OH 45320 Phone: 937-456-8360 Fax: 866-545-5451 | |
Lola Dennis, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 109 E Washington Jackson Rd Ste B, Eaton, OH 45320 Phone: 937-456-2155 Fax: 937-456-2155 | |
Ashley B Grubb, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 450b Washington Jackson Rd Ste 108, Eaton, OH 45320 Phone: 937-456-8330 Fax: 937-456-8335 | |
Mrs. Shelley Marie Barney, PA-C,MPAS Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 450b Washington Jackson Rd Ste 108, Eaton, OH 45320 Phone: 937-456-8330 Fax: 937-456-8335 | |
Amy M Littrell, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 450b Washington Jackson Rd, Suite 104, Eaton, OH 45320 Phone: 937-456-8340 Fax: 937-456-8341 | |
Timothy Michael Mccarty, C-PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 450b Washington Jackson Rd Ste 104, Eaton, OH 45320 Phone: 937-456-8340 Fax: 937-456-8341 | |
John S Allen, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 450b Washington Jackson Rd, Ste 105, Eaton, OH 45320 Phone: 937-456-8350 Fax: 937-456-8351 |